Riptide is a Bay Area biotechnology company developing immune-modulatory therapeutics for fibrosis and cancer. Riptide is pioneering a novel and superior therapeutic approach, targeting CD206, a receptor highly selective to the immune cell complement in tumors and fibrotic lesions.
Address
VallejoCalifornia
United States
